Dolby Laboratories annual ebitda
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Dolby Laboratories EBITDA Growth & History (DLB)
Dolby Laboratories's calculated EBITDA was $352.8M for fiscal 2025.
View full Dolby Laboratories company overviewDolby Laboratories annual ebitda history
| Fiscal year | Period ended | EBITDA | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-09-26 | $352.8M | $18.9M | +5.66% |
| 2024 | 2024-09-27 | $333.9M | $35.6M | +11.93% |
| 2023 | 2023-09-29 | $298.3M | $3.2M | +1.10% |
| 2022 | 2022-09-30 | $295.1M | −$145.2M | −32.98% |
| 2021 | 2021-09-24 | $440.3M | $130.6M | +42.19% |
| 2020 | 2020-09-25 | $309.6M | −$32.6M | −9.52% |
| 2019 | 2019-09-27 | $342.2M | $77.4M | +29.24% |
| 2018 | 2018-09-28 | $264.8M | −$66.7M | −20.11% |
| 2017 | 2017-09-29 | $331.4M | $14.5M | +4.57% |
| 2016 | 2016-09-30 | $316.9M | $34.6M | +12.25% |
| 2015 | 2015-09-25 | $282.4M | −$44.6M | −13.65% |
| 2014 | 2014-09-26 | $327.0M | $28.5M | +9.54% |
| 2013 | 2013-09-27 | $298.5M | −$107.4M | −26.45% |
| 2012 | 2012-09-28 | $405.9M | −$67.9M | −14.32% |
| 2011 | 2011-09-30 | $473.7M | $9.4M | +2.03% |
| 2010 | 2010-09-24 | $464.3M | $71.9M | +18.33% |
| 2009 | 2009-09-25 | $392.4M | $80.8M | +25.93% |
| 2008 | 2008-09-26 | $311.6M | — | — |
Dolby Laboratories quarterly ebitda
Q1.10
Q2.10
Q3.10
Q4.10
Q1.11
Q2.11
Q3.11
Q4.11
Q1.12
Q2.12
Q3.12
Q4.12
Q1.13
Q2.13
Q3.13
Q4.13
Q1.14
Q2.14
Q3.14
Q4.14
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
Q3.26
| Fiscal quarter | Period ended | EBITDA | Change | YoY change |
|---|---|---|---|---|
| Q3 2026 | 2026-06-26 | $56.9M | −$12.7M | −18.19% |
| Q2 2026 | 2026-03-27 | $137.0M | $7.7M | +5.99% |
| Q1 2026 | 2025-12-26 | $86.3M | −$15.9M | −15.59% |
| Q4 2025 | 2025-09-26 | $51.7M | −$16.0M | −23.69% |
| Q3 2025 | 2025-06-27 | $69.6M | $14.5M | +26.28% |
| Q2 2025 | 2025-03-28 | $129.3M | $2.3M | +1.82% |
| Q1 2025 | 2024-12-27 | $102.2M | $18.1M | +21.58% |
| Q4 2024 | 2024-09-27 | $67.7M | $50.1M | +283.95% |
| Q3 2024 | 2024-06-28 | $55.1M | $18.1M | +49.00% |
| Q2 2024 | 2024-03-29 | $127.0M | −$3.5M | −2.66% |
| Q1 2024 | 2023-12-29 | $84.1M | −$29.1M | −25.74% |
| Q4 2023 | 2023-09-29 | $17.6M | −$28.6M | −61.82% |
| Q3 2023 | 2023-06-30 | $37.0M | −$32.1M | −46.50% |
| Q2 2023 | 2023-03-31 | $130.5M | $64.8M | +98.55% |
| Q1 2023 | 2022-12-30 | $113.2M | −$815,000 | −0.71% |
| Q4 2022 | 2022-09-30 | $46.2M | −$19.3M | −29.51% |
| Q3 2022 | 2022-07-01 | $69.1M | −$10.3M | −12.94% |
| Q2 2022 | 2022-04-01 | $65.7M | −$42.7M | −39.40% |
| Q1 2022 | 2021-12-31 | $114.1M | −$72.9M | −38.98% |
| Q4 2021 | 2021-09-24 | $65.5M | $8.5M | +14.86% |
| Q3 2021 | 2021-06-25 | $79.4M | $21.6M | +37.30% |
| Q2 2021 | 2021-03-26 | $108.4M | −$17.5M | −13.90% |
| Q1 2021 | 2020-12-25 | $186.9M | $118.1M | +171.56% |
| Q4 2020 | 2020-09-25 | $57.0M | −$16.5M | −22.42% |
| Q3 2020 | 2020-06-26 | $57.8M | $1.6M | +2.76% |
| Q2 2020 | 2020-03-27 | $125.9M | $2.2M | +1.79% |
| Q1 2020 | 2019-12-27 | $68.8M | −$19.9M | −22.40% |
| Q4 2019 | 2019-09-27 | $73.5M | $41.1M | +126.67% |
| Q3 2019 | 2019-06-28 | $56.3M | $43.2M | +329.25% |
| Q2 2019 | 2019-03-29 | $123.7M | $18.3M | +17.36% |
| Q1 2019 | 2018-12-28 | $88.7M | −$25.1M | −22.08% |
| Q4 2018 | 2018-09-28 | $32.4M | −$9.2M | −22.05% |
| Q3 2018 | 2018-06-29 | $13.1M | −$103.3M | −88.74% |
| Q2 2018 | 2018-03-30 | $105.4M | $19.9M | +23.23% |
| Q1 2018 | 2017-12-29 | $113.8M | $26.0M | +29.54% |
| Q4 2017 | 2017-09-29 | $41.6M | −$8.8M | −17.44% |
| Q3 2017 | 2017-06-30 | $116.4M | $14.3M | +14.01% |
| Q2 2017 | 2017-03-31 | $85.5M | −$17.9M | −17.30% |
| Q1 2017 | 2016-12-30 | $87.9M | $26.9M | +44.06% |
| Q4 2016 | 2016-09-30 | $50.4M | −$4.1M | −7.51% |
| Q3 2016 | 2016-07-01 | $102.1M | $40.0M | +64.33% |
| Q2 2016 | 2016-04-01 | $103.4M | $7.8M | +8.12% |
| Q1 2016 | 2016-01-01 | $61.0M | −$9.1M | −12.93% |
| Q4 2015 | 2015-09-25 | $54.5M | −$18.1M | −24.91% |
| Q3 2015 | 2015-06-26 | $62.1M | −$2.3M | −3.60% |
| Q2 2015 | 2015-03-27 | $95.7M | −$22.0M | −18.67% |
| Q1 2015 | 2014-12-26 | $70.1M | −$2.3M | −3.15% |
| Q4 2014 | 2014-09-26 | $72.6M | $1.9M | +2.62% |
| Q3 2014 | 2014-06-27 | $64.5M | $14.3M | +28.54% |
| Q2 2014 | 2014-03-28 | $117.6M | $20.1M | +20.67% |
| Q1 2014 | 2013-12-27 | $72.3M | −$7.8M | −9.76% |
| Q4 2013 | 2013-09-27 | $70.7M | −$13.5M | −16.01% |
| Q3 2013 | 2013-06-28 | $50.1M | −$29.1M | −36.70% |
| Q2 2013 | 2013-03-29 | $97.5M | −$33.7M | −25.72% |
| Q1 2013 | 2012-12-28 | $80.2M | −$31.1M | −27.93% |
| Q4 2012 | 2012-09-28 | $84.2M | −$38.0M | −31.07% |
| Q3 2012 | 2012-06-29 | $79.2M | −$21.6M | −21.44% |
| Q2 2012 | 2012-03-30 | $131.2M | −$756,000 | −0.57% |
| Q1 2012 | 2011-12-30 | $111.2M | −$7.5M | −6.33% |
| Q4 2011 | 2011-09-30 | $122.2M | $15.6M | +14.63% |
| Q3 2011 | 2011-07-01 | $100.8M | −$3.3M | −3.13% |
| Q2 2011 | 2011-04-01 | $132.0M | −$9.7M | −6.84% |
| Q1 2011 | 2010-12-31 | $118.7M | $6.8M | +6.04% |
| Q4 2010 | 2010-09-24 | $106.6M | — | — |
| Q3 2010 | 2010-06-25 | $104.1M | — | — |
| Q2 2010 | 2010-03-26 | $141.7M | — | — |
| Q1 2010 | 2009-12-25 | $112.0M | — | — |
Dolby Laboratories ebitda trends
Over the last five fiscal years, Dolby Laboratories's ebitda increased from $309.6M to $352.8M, a change of $43.2M. The latest reported quarter, Q3 2026, shows $56.9M.
About the metric
What EBITDA means
EBITDA is a measure of operating performance before interest, taxes, depreciation, and amortization. It can help compare operating results, but it is not a substitute for cash flow or GAAP net income.
Calculation and source
How TickerStat calculates EBITDA
TickerStat calculates EBITDA as operating income plus reported depreciation and amortization for aligned fiscal periods. It is calculated data, not adjusted EBITDA or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Dolby Laboratories source filings ↗Community posts
Dolby expands its technology partnership across Meta’s devices and apps
Dolby ($DLB) and Meta ($META) expanded their partnership to bring Dolby Atmos capture to Meta AI glasses and enable users to share the resulting immersive audio experiences through Instagram. The agreement also extends Dolby Vision and Dolb ...
